Lidocaine Irrigation in Shoulder Arthroscopy

Postoperative Pain Clinical Trial

Official title:

Efficacy of Lidocaine Saline Irrigation in Patients Undergoing Shoulder Arthroscopy: Randomized Controlled Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05624957
• Other study ID #: 475:10/2022
• Status: Completed
• Phase: N/A
• Start date: November 25, 2022
• Est. completion date: August 1, 2023

Study information

• Verified date: October 2023
• Source: Minia University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Arthroscopic shoulder surgery is often associated with severe postoperative pain that is often significant enough to interfere with initial recovery and rehabilitation. The pain that can be difficult to manage without large dose of opioid.

The study aim to explore the effect of continuous irrigation of fluids mixed with lidocaine and epinephrine for analgesic consumption and postoperative pain after shoulder arthroscopy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: August 1, 2023
• Est. primary completion date: May 1, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 20 Years to 60 Years

Eligibility

Inclusion Criteria:

• Age 20-60

• Both genders

• Shoulder arthroscopy

• ASA I-III

Exclusion Criteria:

• Drug allergy

• Psychiatric disorder

• Opioid dependence

• Liver disease

• Patient refuse

Related Conditions & MeSH terms

• Analgesia
• Pain, Postoperative
• Postoperative Pain

Intervention

Drug:
• Lidocaine epinephrine
Under aseptic condition every one litre of fluid irrigation will be mixture with 10 ml of lidocaine 2% and 0.25mg epinephrine and the last one use before end of surgery dexamethasone 8 mg will be added.
• Epinephrin
0.25 mg epinephrine mixed with one litre of fluid irrigation

Locations

Country	Name	City	State
Egypt	Minia University Hospital	Minya

Sponsors (1)

Lead Sponsor	Collaborator
Minia University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	total analgesic consumption	total nalbuphine consumed one day after surgery	24 hours
Secondary	first analgesic request	time of PCA request	24 hours
Secondary	Visual analogue pain score	pain intensity at rest and movement from 0-10 which 0 no pain and 10 the worst pain	24 hours